Physiologic approach for coronary intervention
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
When invasively assessing coronary artery disease, the primary goal should be to determine whether the disease is causing a patient’s symptoms and whether it is likely to cause future cardiac events. The presence of myocardial ischemia is our best gauge of whether a lesion is responsible for symptoms and likely to result in a future cardiac event. In the catheterization laboratory, fractional flow reserve (FFR) measured with a coronary pressure wire is the reference standard for identifying ischemia-producing lesions. Its spatial resolution is unsurpassed with it not only being vessel-specific, but also lesion-specific. There is now a wealth of data supporting the accuracy of measuring FFR to identify ischemia-producing lesions. FFR-guided percutaneous coronary intervention of these lesions results in improved outcomes and saves resources. Non-hemodynamically significant lesions can be safely managed medically with a low rate of subsequent cardiac events.
Abstract
When invasively assessing coronary artery disease, the primary goal should be to determine whether the disease is causing a patient’s symptoms and whether it is likely to cause future cardiac events. The presence of myocardial ischemia is our best gauge of whether a lesion is responsible for symptoms and likely to result in a future cardiac event. In the catheterization laboratory, fractional flow reserve (FFR) measured with a coronary pressure wire is the reference standard for identifying ischemia-producing lesions. Its spatial resolution is unsurpassed with it not only being vessel-specific, but also lesion-specific. There is now a wealth of data supporting the accuracy of measuring FFR to identify ischemia-producing lesions. FFR-guided percutaneous coronary intervention of these lesions results in improved outcomes and saves resources. Non-hemodynamically significant lesions can be safely managed medically with a low rate of subsequent cardiac events.
참고문헌 (17)
- Hachamovitch R, "Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction", Circulation, 97, pp.535~543 (1998)
- Shaw LJ, "Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy", Circulation, 117, pp.1283~1291 (2008)
- Pijls NH, "Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study", J Am Coll Cardiol, 49, pp.2105~2111 (2007)
- Lima RS, "Incremental value of combined perfusion and function over perfusion alone by gated SPECT myocardial perfusion imaging for detection of severe three-vessel coronary artery disease", J Am Coll Cardiol, 42, pp.64~70 (2003)
- Meijboom WB, "Comprehensive assessment of coronary artery stenoses: computed tomography coronary angiography versus conventional coronary angiography and correlation with fractional flow reserve in patients with stable angina", J Am Coll Cardiol, 52, pp.636~643 (2008)
- Tonino PA, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention", N Engl J Med, 360, pp.213~224 (2009)
- Pijls NH, "Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty", Circulation, 87, pp.1354~1367 (1993)
- Pijls NH, "Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses", N Engl J Med, 334, pp.1703~1708 (1996)
- Kern MJ, "Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology", Circulation, 114, pp.1321~1341 (2006)
- Bech GJ, "Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial", Circulation, 103, pp.2928~2934 (2001)
- De Bruyne B, "Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease", N Engl J Med, 367, pp.991~1001 (2012)
- Lindstaedt M., "Patient stratification in left main coronary artery disease: rationale from a contemporary perspective", Int J Cardiol, 130, pp.326~334 (2008)
- Hamilos M, "Long-term clinical outcome after fractional f low reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis", Circulation, 120, pp.1505~1512 (2009)
- Pijls NH, "Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study", J Am Coll Cardiol, 56, pp.177~184 (2010)
- Tonino PA, "Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation", J Am Coll Cardiol
- Kern MJ, "Current concepts of integrated coronary physiology in the catheterization laboratory", J Am Coll Cardiol, 55, pp.173~185 (2010)
- Ntalianis A, "Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction", JACC Cardiovasc Interv, 3, pp.1274~1281 (2010)